Apolipoprotein F (APOF) Antibody

Este producto es parte de APOF - Apolipoprotein F
Product Graph
637€ (100 µl)

Por favor contáctenos para obtener información detallada sobre el precio y disponibilidad.

935106861
info@markelab.com
name
Apolipoprotein F (APOF) Antibody
category
Primary Antibodies
provider
Abbexa
reference
abx111028
tested applications
ELISA, WB, IHC

Description

Apolipoprotein F Antibody is a Rabbit Polyclonal antibody against Apolipoprotein F.

Documents del producto

Instrucciones
Data sheet
Descargar

Product specifications

Category
Primary Antibodies
Immunogen Target
Apolipoprotein F (APOF)
Host
Rabbit
Reactivity
Human
Recommended Dilution
Optimal dilutions/concentrations should be determined by the end user.
Clonality
Polyclonal
Conjugation
Unconjugated
Isotype
IgG
Purification
Antigen Affinity Chromatography.
Size 1
100 µl
Form
Liquid
Tested Applications
ELISA, WB, IHC
Buffer
PBS, pH 7.3, containing 0.1% Sodium Azide and 50% Glycerol.
Availability
Shipped within 5-10 working days.
Storage
Aliquot and store at -20°C. Avoid repeated freeze/thaw cycles.
Dry Ice
No
UniProt ID
Q13790
Gene ID
319
OMIM
107760
Alias
APOF, Apo-F, LTIP, apolipoprotein F,Apo F
Background
Antibody anti-APOF
Status
RUO

Descripción

Apolipoprotein F (APOF) is a lesser-known but essential component of the apolipoprotein family, predominantly found in high-density lipoproteins (HDL) and low-density lipoproteins (LDL). ApoF plays a regulatory role in cholesteryl ester transfer protein (CETP) activity, which facilitates the transfer of cholesteryl esters from HDL to triglyceride-rich lipoproteins like VLDL and LDL. By modulating CETP activity, ApoF influences cholesterol distribution, lipid metabolism, and the balance between HDL and LDL particles. ApoF is mainly synthesized in the liver and circulates in plasma, with elevated levels observed in dyslipidemia and cardiovascular diseases. ApoF is thought to act as a negative regulator of CETP, reducing cholesterol transfer and preserving HDL levels, which are vital for reverse cholesterol transport and cardiovascular health. Its role in maintaining HDL function positions ApoF as a potential therapeutic target in atherosclerosis and other metabolic disorders. Further research is exploring its contribution to lipid homeostasis, inflammation, and cholesterol efflux pathways, which are critical for combating cardiovascular disease and lipid-related pathologies.

Related Products

EH2657

Human ApoF(Apolipoprotein F) ELISA Kit

Ver Producto
EM0847

Mouse APO-F(Apolipoprotein F) ELISA Kit

Ver Producto
FNab00501

anti- APOF antibody

Minor apolipoprotein that associates with LDL. Inhibits cholesteryl ester transfer protein(CETP) activity and appears to be an important regulator of cholesterol transport. Also associates to a lesser degree with VLDL, Apo-AI and Apo-AII.

Ver Producto